Skip to content

Healthy.io Method Comparison & User Performance Study

A Comparative, Controlled Study to Evaluate the Clinical Accuracy and User Performance of the Dip Home-Based Dipstick Analyzer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02785445
Enrollment
425
Registered
2016-05-27
Start date
2015-10-31
Completion date
2017-09-30
Last updated
2017-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Kidney Failure, Urinary Tract Infection

Brief summary

The objectives of the Healthy.io Method Comparison and User Performance Study are: 1. To evaluate the performance of Dip.io Device in comparison to the ACON U500 Mission® U500 Urine Analyzer. 2. To evaluate the user performance of Dip.io Device under actual use conditions (home environment) based on a user questionnaire and rating scale.

Interventions

DEVICEDip.io Home Based Dipstick Analyzer

First intervention (assigned to the All participants arm).

DEVICEACON U500 Mission® U500 Urine Analyzer

Second intervention (assigned to the All participants arm).

Sponsors

Healthy.io Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

1. Subject is male or female, 18-80 years of age 2. Subjects who are healthy or pregnant; or 3. Subjects diagnosed with a disease that normally represents itself with an abnormal concentration of one of the following urine analytes; Glucose, Bilirubin, Ketone (Acetoacetic acid), Specific Gravity, Blood, pH, Protein, Urobilinogen, Leukocytes, and Nitrite (examples of such diseases include the following): * diabetes Type I, Type II, or gestational diabetes (Type III) or, * urinary tract infection (UTI) * heart disease * kidney disease * liver disease * pregnant women with preeclampsia, gestational diabetes or UTI * any pathological findings which might be identified by the urine test (according to the physician discretion) 4. Subject is capable and willing to provide informed consent. 5. Subject has facility with both hands. 6. Subject is capable and willing to adhere to the study procedures 7. Subject is familiar with the use of a smartphone.

Exclusion criteria

1. Subject has dementia. 2. Subject has mental disorders. 3. Subject is visually impaired (cannot read the user manual). 4. Subject cannot collect urine in receptacle. 5. Any other reason that might preclude the subject from the study.

Design outcomes

Primary

MeasureTime frameDescription
Exact and ±1 agreement to compared deviceThrough study completion, an average of 1 monthThe primary objective of the study is to evaluate the exact agreement and the ±1 color block match of the Dip.io compared to the predicate device, for each analyte concentration (block).

Secondary

MeasureTime frameDescription
User performanceThrough study completion, an average of 1 monthAll subjects tested should be able to complete device related tasks. The healthcare professionals also recorded their assessment of each subject's use of the new device. The subjects and healthcare inputs were recorded using study questionnaires.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026